Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6904
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer ; volume:11 ; number:1 ; day:3 ; month:2 ; year:2011 ; pages:1-8 ; date:12.2011
BMC clinical pharmacology ; 11, Heft 1 (3.2.2011), 1-8, 12.2011
- Creator
-
Howes, Jan B.
- Contributor
-
de Souza, Paul L.
West, Leanne
Huang, Li Jiu
Howes, Laurence G.
SpringerLink (Online service)
- DOI
-
10.1186/1472-6904-11-1
- URN
-
urn:nbn:de:1111-2016072030722
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Howes, Jan B.
- de Souza, Paul L.
- West, Leanne
- Huang, Li Jiu
- Howes, Laurence G.
- SpringerLink (Online service)
Other Objects (12)
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats
Pharmacokinetics of dexmedetomidine in anaesthetized horses following repeated subcutaneous administration and intravenous constant rate infusion
Pharmacokinetics and Safety of Vedolizumab Following Administration of a Single Intravenous Dose in Healthy Chinese Subjects
Meperidine pharmacokinetics and effects on physiologic parameters and thermal threshold following intravenous administration of three doses to horses
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration
Pharmacokinetics of flunixin meglumine in mature swine after intravenous, intramuscular and oral administration
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
Covariates of intravenous paracetamol pharmacokinetics in adults
Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration
The rate of dasotraline brain entry is slow following intravenous administration
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats
Pharmacokinetics of dexmedetomidine in anaesthetized horses following repeated subcutaneous administration and intravenous constant rate infusion
Pharmacokinetics and Safety of Vedolizumab Following Administration of a Single Intravenous Dose in Healthy Chinese Subjects
Meperidine pharmacokinetics and effects on physiologic parameters and thermal threshold following intravenous administration of three doses to horses
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration
Pharmacokinetics of flunixin meglumine in mature swine after intravenous, intramuscular and oral administration
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
Covariates of intravenous paracetamol pharmacokinetics in adults
Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration
The rate of dasotraline brain entry is slow following intravenous administration
Physiologically based modeling of lisofylline pharmacokinetics following intravenous administration in mice
Pharmacokinetics of lotilaner following a single oral or intravenous administration in cats
Pharmacokinetics of dexmedetomidine in anaesthetized horses following repeated subcutaneous administration and intravenous constant rate infusion
Pharmacokinetics and Safety of Vedolizumab Following Administration of a Single Intravenous Dose in Healthy Chinese Subjects
Meperidine pharmacokinetics and effects on physiologic parameters and thermal threshold following intravenous administration of three doses to horses
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration
Pharmacokinetics of flunixin meglumine in mature swine after intravenous, intramuscular and oral administration
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
Covariates of intravenous paracetamol pharmacokinetics in adults
Pharmacokinetics and subjective effects of 1P‐LSD in humans after oral and intravenous administration